Sun Pharmaceuticals

FDA continues import ban on Sun Pharma drugs despite pleas

21 May 2014

SC blasts manner of stalling Sun-Ranbaxy merger

21 May 2014

Sun Pharma denied the charge but said the share purchase by Silver Street, a limited-liability partnership firm owned by two subsidiaries of Sun Pharma, was being annulled

Sun Pharma settles litigation over Novaris’s cancer drug Gleevec

15 May 2014

Sun Pharma closes Detroit facility to consolidate US operations

03 May 2014

HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations

30 Apr 2014

The order was in response to a petition for a Sebi inquiry into possible insider trading in Ranbaxy shares that saw heavy trading before the merger with Sun Pharma was announced

Sun Pharma to make mandatory open offer to buy 28.1% of Zenotech

12 Apr 2014

Ranbaxy drug flows to Europe, US to dry up

09 Apr 2014

Sun Pharmaceutical Industries plans to phase out sales of Ranbaxy’s branded generic drugs in the US while continuing sales in other markets

Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal

07 Apr 2014

The merger will create India's largest pharmaceutical company and the world's fifth largest speciality generics company with annual emerging market sales nearing Rs6,000 crore

And now, USFDA bans imports from Sun Pharma unit

13 Mar 2014

The US regulator has been cracking down heavily on Indian generic pharmaceutical firms such as Ranbaxy and Wockhardt for alleged failure to comply with its manufacturing norms

Sun Pharma Q2 net jumps four-fold to Rs1,362 crore

14 Nov 2013

Sun Pharma does well, but Pfizer settlement puts it in red

10 Aug 2013

Sun Pharma gets US nod to sell generic diabetes drug

13 Jul 2013

Sun Pharma settles Teva patent spat with Pfizer for $550 mn

13 Jun 2013

Teva, Sun Pharma to pay Pfizer $2.15 bn to settle patent suit

12 Jun 2013

Teva, the world’s largest generic drug firm, will pay $1.6 billion of the settlement amount while Sun Pharmaceuticals will pay the remaining $550 million

Sun Pharma in discussion to acquire controlling stake in Meda AB

31 May 2013

Sun Pharmaceutical Industries is in discussions to acquire a controlling stake in Swedish drugmaker Meda AB  for around $5 billion to boost its generics business in developed markets

Sun Pharma calls off $600-million buyout of Taro

08 Feb 2013

Sun Pharma's latest buyout offer of $39.50 per share for 15 million scrips was 61 per cent higher than its previous offer of $24.50, which Taro had rejected

Sun Pharma to buy some generic business of Takeda's US subsidiary URL Pharma

18 Dec 2012

Sun Pharma’s US unit to buy URL Pharma

18 Dec 2012

Sun Pharma to buy US dermatology company Dusa Pharmaceuticals for $230 mn

09 Nov 2012

Sun Pharma gets partial US FDA clearance to resume US operations

29 Aug 2012

Grand Slam Asset Management rejects Sun Pharma’s sweetened offer for Taro

14 Aug 2012

Sun Pharma to buy out Israel’s Taro for $571 million

13 Aug 2012

Taro Pharmaceutical Industries has agreed to a new offer of Sun Pharma, which already owns 66.3 per cent of Taro, to pay $39.50 per share for the remaining stake held by Taro’s minority shareholders

Sun Pharma to spin off domestic formulations business into Sun Resins & Polymers

11 Aug 2012

Sun Pharmaceuticals eyes German generic-drug maker Stada: report

03 Aug 2012

Israel’s Taro rejects Sun Pharma’s $367-mn buyout offer

20 Jul 2012

Mumbai-based Sun Pharma, India's largest pharmaceutical company by market capitalisation, already owns 66.3 per cent of Taro

View details about the software product Informachine News Trackers